Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs MedLeanRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MedLeanRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 149 · Grade C

MedLeanRx

Visit MedLeanRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make MedLeanRx a bad call — it's best for texas patients comparing a starting-dose plan with a branded prescription route who want an itemized quote before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
79
Transparency
90
88
Access Breadth
93
68
Clinical Oversight
92
77
Track Record
88
68
CoreAge RxBrief Score 94 · 71MedLeanRx

Price, coverage & the tracker

CoreAge RxMedLeanRx
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$149/mo starting-dose offer

Compounded semaglutide vial; confirm the full prescribed dose and charge. Texas only.

Full price details

Compounded semaglutide offered; complete dose-specific quote unknown; $149/month starting-dose vial advertised; earlier listing: From $149/mo (starting dose, promotional rate, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$269/mo starting-dose offer

Injection plan; confirm formulation and full dose-specific charge. Texas only. Brand-care fee of $99 excludes medication.

Full price details

Current tirzepatide formulation and complete quote unknown; injection plan advertised $269/month at starting dose; earlier listing: From $269/mo (starting dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeTexas only according to current practice and product pages
Brand-name accessNot confirmedNamed branded options have a $99/month professional-service charge plus medication; that is not an all-inclusive drug price.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

MedLeanRx: Semaglutide vial $149 and tirzepatide injection $269 are starting-dose offers. Branded routes advertise $99 for professional services plus medication, not a $99 drug plan.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.